Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of toll-like receptor 4 expression

Neuroscience Letters

Volumn 526, Issue 1, 2012, Pages 54-58

  Yan, Jian E ^a   Yuan, Wei ^b   Lou, Xiaoli ^b   Zhu, Tao ^b  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Diabetes; Interleukin 1 beta; Neuropathic pain; Toll like receptor; Tumor necrosis factor alpha

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; STREPTOZOCIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; HEAT SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HOT TEMPERATURE; HYPERALGESIA; INTERLEUKIN-1BETA; MALE; NEURALGIA; PAIN MEASUREMENT; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPINAL CORD; STREPTOZOCIN; TOLL-LIKE RECEPTOR 4; TOUCH; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84865615523     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.012     Document Type: Article

References (30)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Bettoni I., Comelli F., Rossini C., Granucci F., Giagnoni G., Peri F., Costa B. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008, 56:1312-1319.
3. Boulton A.J. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004, 47:1343-1353.
4. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. Journal of Neuropathology and Experimental Neurology 2002, 61:1013-1021.
5. Cao L., Tanga F.Y., Deleo J.A. The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain. Neuroscience 2009, 158:896-903.
6. Courteix C., Eschalier A., Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 1993, 53:81-88.
7. Dasu M.R., Ramirez S., Isseroff R.R. Toll-like receptors and diabetes: a therapeutic perspective. Clinical Science (London) 2012, 122:203-214.
8. Dominguez E., Mauborgne A., Mallet J., Desclaux M., Pohl M. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. The Journal of Neuroscience 2010, 30:5754-5766.
9. Dyck P.J., Larson T.S., O'Brien P.C., Velosa J.A. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 2000, 23:510-517.
10. Fresno M., Alvarez R., Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Archives of Physiology and Biochemistry 2011, 117:151-164.
11. Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clinical Science (London) 2011, 121:367-387.
12. Jensen T.S., Backonja M.M., Hernandez Jimenez S., Tesfaye S., Valensi P., Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes & Vascular Disease Research 2006, 3:108-119.
13. Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. Journal of Neuroscience Research 2006, 83:711-730.
14. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., Choi S.Y., Park K., Kim J.S., Akira S., Na H.S., Oh S.B., Lee S.J. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. The Journal of Biological Chemistry 2007, 282:14975-14983.
15. Lee J.H., McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain 1992, 50:231-236.
16. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:8514-8519.
17. Li F., Yang N., Zhang L., Tan H., Huang B., Liang Y., Chen M., Yu X. Increased expression of toll-like receptor 2 in rat diabetic nephropathy. American Journal of Nephrology 2010, 32:179-186.
18. Lien E., Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Current Molecular Medicine 2009, 9:52-68.
19. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nature Reviews: Immunology 2011, 11:807-822.
20. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Seminars in Immunology 2007, 19:3-10.
21. Morrow T.J. Animal models of painful diabetic neuropathy: the STZ rat model. Current Protocols in Neuroscience 2004, (Chapter 9, 9.18.1-9.18.11).
22. Obata K., Katsura H., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Akira S., Noguchi K. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. Journal of Neurochemistry 2008, 105:2249-2259.
23. Obrosova I.G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 2009, 6:638-647.
24. Rakieten N., Rakieten M.L., Nadkarni M.R. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemotherapy Reports 1963, 29:91-98.
25. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nature Cell Biology 2007, 9:1081-1088.
26. Schranz D.B., Lernmark A. Immunology in diabetes: an update. Diabetes/Metabolism Reviews 1998, 14:3-29.
27. Sommer C. Painful neuropathies. Current Opinion in Neurology 2003, 16:623-628.
28. Spirig R., Tsui J., Shaw S. The emerging role of TLR and innate immunity in cardiovascular disease. Cardiology Research and Practice 2012, 2012:181394.
29. Tanga F.Y., Nutile-McMenemy N., DeLeo J.A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:5856-5861.
30. Veves A., Backonja M., Malik R.A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Medicine 2008, 9:660-674.